SCHEMBL7229934

SCHEMBL7229934

COc1ccc(COc2cc(Cl)cc(N3CCNCC3)c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 5/20 0.55
HTR3A P46098 4/20 0.55
HTR3E A5X5Y0 3/20 0.55
HTR3B O95264 3/20 0.55
HTR3D Q70Z44 3/20 0.55
HTR3C Q8WXA8 3/20 0.55
SIGMAR1 Q99720 2/20 0.55
CHRM2 P08172 1/20 0.51
CHRM4 P08173 1/20 0.51
CHRM1 P11229 1/20 0.51
CHRM3 P20309 1/20 0.51
HTR1A P08908 2/20 0.47
HTR1D P28221 1/20 0.47
HTR1B P28222 1/20 0.47
HTR2C P28335 2/20 0.45
LTA4H P09960 2/20 0.45
HRH3 Q9Y5N1 1/20 0.44
GUSB P08236 1/20 0.44
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16795209 0.86 ADRB1 (0.55) ADRB1HTR3AHTR3EHTR3BHTR3D
SCHEMBL7236768 0.85 ADRB1 (0.55) ADRB1HTR3AHTR3EHTR3BHTR3D
SCHEMBL4925469 0.84 ADRB1 (0.77) ADRB1HTR3AHTR3EHTR3BHTR3D
SCHEMBL2231843 0.76 HRH3 (0.64) SIGMAR1HRH3TP53
SCHEMBL13667485 0.74 GRM5 (0.54) GRM5
SCHEMBL26236040 0.73 ADRB1 (0.53) ADRB1HTR3AHTR3EHTR3BHTR3D
SCHEMBL12916421 0.73 ADRB1 (0.65) ADRB1HTR3AHTR3EHTR3BHTR3D
SCHEMBL234280 0.73 ADRB1 (1.00) ADRB1HTR3AHTR3EHTR3BHTR3D
SCHEMBL2410870 0.73 ADRB1 (1.00) ADRB1HTR3AHTR3EHTR3BHTR3D
SCHEMBL443521 0.73 ADRB1 (1.00) ADRB1HTR3AHTR3EHTR3BHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552018-B1 As antitumor agents DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-04-22 US disclosed
US-6169086-B1 AN ANTITUMOR AGENT FOR TREATING TUMOR RESISTANT TO 5-FLUOROURACIL TYPE DRUGS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-1022270-A1 PYRAZOLE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2000-07-26 EP disclosed